Elimination study of intact lipid nanocapsules after intravenous rat administration

Nanomedicine (Lond). 2024;19(13):1123-1131. doi: 10.2217/nnm-2024-0003. Epub 2024 Sep 20.

Abstract

Aim: The present study investigated renal elimination after intravenous administration of four different formulations of lipid nanocapsules (LNCs) containing dyes adapted to Förster resonance energy transfer (FRET-LNCs).Materials & methods: FRET-LNCs of 85 or 50 nm with or without a pegylated surface were injected and collected in the blood or urine of rats at different time points. Quantitative analysis was performed to measure intact FRET-LNCs.Results & conclusion: No intact LNCs were found in urine (0 particles/ml) for all formulations. The 50-nm pegylated LNCs were eliminated faster from the blood, whereas 85-nm pegylated LNCS were eliminated slower than nonpegylated LNCs. Elimination of FRET-LNCs was mainly due to liver tissue interaction and not renal elimination.

Keywords: FRET; drug delivery; lipid nanocapsules; pharmacokinetics; renal elimination.

Plain language summary

This study confirmed that the elimination of FRET LNCs is likely mainly due to liver tissue interaction and not renal elimination. #nanomedicines #lipidnanocapsules #FRET #pharmacokinetic #biodistribution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous*
  • Animals
  • Fluorescence Resonance Energy Transfer
  • Kidney / drug effects
  • Kidney / metabolism
  • Lipids* / chemistry
  • Liver / metabolism
  • Male
  • Nanocapsules* / chemistry
  • Particle Size
  • Polyethylene Glycols* / chemistry
  • Rats

Substances

  • Nanocapsules
  • Lipids
  • Polyethylene Glycols